UNSPSC 85694176: Replacement of right humeral shaft with nonautologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to replacement of right humeral shaft with nonautologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0PRF4KZ

UNSPSC 85694176 Replacement of right humeral shaft with nonautologous tissue substitute, percutaneous endoscopic approach is a Commodity code that does not reflect the kinds of services state and local governments are actually buying under this classification in practice. The recent solicitations tagged to this code involve medical evaluation and occupational health surveillance, pharmacy benefit management, temporary health professional staffing, and specialty surgical carve-out programs—none of which involve orthopedic surgical procedures or implants. The mismatch suggests either a data-entry error in the UNSPSC tagging or that this code is not in active use for state and local procurement. No concrete procurement activity for humeral shaft replacement or related orthopedic surgical interventions appears in the recent-opportunities block.

The six opportunities present in the source cover employee health benefits administration, occupational medicine, independent medical evaluations for disability determinations, and temporary clinical staffing—work genuinely being bought by city retirement offices, county health systems, state transportation departments, and county boards across Arizona, California, Florida, and Washington. The code as named does not meaningfully describe any of this work. Unless the source reflects a systematic misclassification event across multiple jurisdictions, this code should be monitored but not actively pursued until the tagging error is resolved or genuine orthopedic-implant procurement appears in future opportunities.